ATOS - 2.48 Pre-market now at 2.55/2.65 Atossa Genetics Says It's Advancing Studies of Its Intraductal Microcatheter to Deliver T-cells to Tumor Site http://stockcharts.com/c-sc/sc?s=ATOS&p=D&b=5&g=0&i=t34777404484&r=1531917586926